Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

Por Loi, Sherene
Publicado em 2013

Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?

Por Stagg, John, Andre, Fabrice, Loi, Sherene
Publicado em 2012

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

Por Zardavas, Dimitrios, Phillips, Wayne A, Loi, Sherene
Publicado em 2014

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

Por Criscitiello, Carmen, Fumagalli, Debora, Saini, Kamal S, Loi, Sherene
Publicado em 2010

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context

Por Abraham, Gad, Kowalczyk, Adam, Loi, Sherene, Haviv, Izhak, Zobel, Justin
Publicado em 2010

A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes

Por Haibe-Kains, Benjamin, Desmedt, Christine, Loi, Sherene, Culhane, Aedin C., Bontempi, Gianluca, Quackenbush, John, Sotiriou, Christos
Publicado em 2012

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

Por Loi, Sherene, Pommey, Sandra, Haibe-Kains, Benjamin, Beavis, Paul A., Darcy, Phillip K., Smyth, Mark J., Stagg, John
Publicado em 2013

Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy

Por Stagg, John, Loi, Sherene, Divisekera, Upulie, Ngiow, Shin Foong, Duret, Helene, Yagita, Hideo, Teng, Michele W., Smyth, Mark J.
Publicado em 2011

Relevance of tumor-infiltrating lymphocytes in breast cancer

Por Dushyanthen, Sathana, Beavis, Paul A., Savas, Peter, Teo, Zhi Ling, Zhou, Chenhao, Mansour, Mariam, Darcy, Phillip K., Loi, Sherene
Publicado no BMC Med (2015)

CD73: A potential biomarker for anti-PD-1 therapy

Por Beavis, Paul A, Slaney, Clare Y, Milenkovski, Nicole, Henderson, Melissa A, Loi, Sherene, Stagg, John, Kershaw, Michael H, Darcy, Phillip K
Publicado no Oncoimmunology (2015)

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer

Por Loi, Sherene, Sotiriou, Christos, Haibe-Kains, Benjamin, Lallemand, Francoise, Conus, Nelly M, Piccart, Martine J, Speed, Terence P, McArthur, Grant A
Publicado em 2009

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy

Por Azim, Hatem A, Peccatori, Fedro A, Brohée, Sylvain, Branstetter, Daniel, Loi, Sherene, Viale, Giuseppe, Piccart, Martine, Dougall, William C, Pruneri, Giancarlo, Sotiriou, Christos
Publicado no Breast Cancer Res (2015)

Identification of Novel Ras-Cooperating Oncogenes in Drosophila melanogaster: A RhoGEF/Rho-Family/JNK Pathway Is a Central Driver of Tumorigenesis

Por Brumby, Anthony M., Goulding, Karen R., Schlosser, Tanja, Loi, Sherene, Galea, Ryan, Khoo, Peytee, Bolden, Jessica E., Aigaki, Toshiro, Humbert, Patrick O., Richardson, Helena E.
Publicado em 2011

Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer

Por Loi, Sherene, Michiels, Stefan, Lambrechts, Diether, Fumagalli, Debora, Claes, Bart, Kellokumpu-Lehtinen, Pirkko-Liisa, Bono, Petri, Kataja, Vesa, Piccart, Martine J., Joensuu, Heikki, Sotiriou, Christos
Publicado em 2013

PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer

Por Loi, Sherene, Michiels, Stefan, Baselga, Jose, Bartlett, John M. S., Singhal, Sandeep K., Sabine, Vicky S., Sims, Andrew H., Sahmoud, Tarek, Dixon, J. Michael, Piccart, Martine J., Sotiriou, Christos
Publicado em 2013

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

Por Bottai, Giulia, Raschioni, Carlotta, Losurdo, Agnese, Di Tommaso, Luca, Tinterri, Corrado, Torrisi, Rosalba, Reis-Filho, Jorge S., Roncalli, Massimo, Sotiriou, Christos, Santoro, Armando, Mantovani, Alberto, Loi, Sherene, Santarpia, Libero
Publicado no Breast Cancer Res (2016)

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial

Por Sonnenblick, Amir, Brohée, Sylvain, Fumagalli, Debora, Rothé, Françoise, Vincent, Delphine, Ignatiadis, Michael, Desmedt, Christine, Salgado, Roberto, Sirtaine, Nicolas, Loi, Sherene, Neven, Patrick, Loibl, Sibylle, Denkert, Carsten, Joensuu, Heikki, Piccart, Martine, Sotiriou, Christos
Publicado no Oncotarget (2015)

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Ra...

Por Verma, Sunil, Bartlett, Cynthia Huang, Schnell, Patrick, DeMichele, Angela M., Loi, Sherene, Ro, Jungsil, Colleoni, Marco, Iwata, Hiroji, Harbeck, Nadia, Cristofanilli, Massimo, Zhang, Ke, Thiele, Alexandra, Turner, Nicholas C., Rugo, Hope S.
Publicado no Oncologist (2016)

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Por Duchnowska, Renata, Pęksa, Rafał, Radecka, Barbara, Mandat, Tomasz, Trojanowski, Tomasz, Jarosz, Bożena, Czartoryska-Arłukowicz, Bogumiła, Olszewski, Wojciech P., Och, Waldemar, Kalinka-Warzocha, Ewa, Kozłowski, Wojciech, Kowalczyk, Anna, Loi, Sherene, Biernat, Wojciech, Jassem, Jacek
Publicado no Breast Cancer Res (2016)

Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data

Por Lönnstedt, Ingrid M, Caramia, Franco, Li, Jason, Fumagalli, Debora, Salgado, Roberto, Rowan, Andrew, Salm, Max, Kanu, Nnennaya, Savas, Peter, Horswell, Stuart, Gade, Stephan, Loibl, Sibylle, Neven, Patrick, Sotiriou, Christos, Swanton, Charles, Loi, Sherene, Speed, Terence P
Publicado no Genome Biol (2014)